Maria Shvedova, Ph.D., M.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reperfusion Injury | 2 | 2019 | 1071 | 0.840 |
Why?
|
| Cartilage | 1 | 2020 | 806 | 0.600 |
Why?
|
| Bone Diseases | 1 | 2020 | 423 | 0.600 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 469 | 0.540 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 730 | 0.540 |
Why?
|
| Brain Ischemia | 2 | 2021 | 3260 | 0.530 |
Why?
|
| Cerebral Infarction | 1 | 2019 | 1039 | 0.510 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 1632 | 0.460 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 1003 | 0.380 |
Why?
|
| Stroke | 2 | 2021 | 9256 | 0.340 |
Why?
|
| MicroRNAs | 1 | 2020 | 3655 | 0.260 |
Why?
|
| Aging | 1 | 2021 | 8358 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5405 | 0.200 |
Why?
|
| Reperfusion | 1 | 2021 | 290 | 0.190 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2021 | 465 | 0.160 |
Why?
|
| Ginsenosides | 1 | 2017 | 10 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2017 | 12 | 0.160 |
Why?
|
| Anthracenes | 1 | 2017 | 89 | 0.160 |
Why?
|
| Acetonitriles | 1 | 2017 | 50 | 0.160 |
Why?
|
| Benzothiazoles | 1 | 2017 | 248 | 0.150 |
Why?
|
| Oximes | 1 | 2017 | 317 | 0.140 |
Why?
|
| Chondrocytes | 1 | 2020 | 769 | 0.140 |
Why?
|
| Quinoxalines | 1 | 2017 | 298 | 0.140 |
Why?
|
| Wound Healing | 2 | 2022 | 2800 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2017 | 456 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2018 | 805 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 1005 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 2748 | 0.100 |
Why?
|
| Animals | 6 | 2022 | 170486 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3464 | 0.090 |
Why?
|
| Skin | 1 | 2022 | 4325 | 0.090 |
Why?
|
| Cholesterol | 1 | 2017 | 2866 | 0.080 |
Why?
|
| Stem Cells | 1 | 2020 | 3593 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 2734 | 0.070 |
Why?
|
| Mice | 3 | 2022 | 80876 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2878 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2017 | 2048 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2019 | 15274 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2018 | 6255 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18375 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2017 | 3228 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12447 | 0.040 |
Why?
|
| Crystallization | 1 | 2017 | 529 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 10857 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10040 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2017 | 644 | 0.030 |
Why?
|
| Humans | 5 | 2021 | 708843 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23950 | 0.030 |
Why?
|
| Histones | 1 | 2022 | 2579 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2022 | 4299 | 0.030 |
Why?
|
| Chromatin | 1 | 2022 | 2693 | 0.030 |
Why?
|
| Brain | 1 | 2017 | 24969 | 0.020 |
Why?
|
| Male | 2 | 2022 | 349524 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 22989 | 0.020 |
Why?
|
| Female | 1 | 2019 | 375205 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20320 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 61932 | 0.010 |
Why?
|